1.
Pakulska AO, Rządzińska N, Błoch AM, et al. DIFFERENCES IN SAFETY PROFILE AND ADVERSE EFFECTS OF ORAL AND SUBCUTANEOUS GLP-1 ANALOGUES: A SYSTEMATIC REVIEW AND REAL-WORLD DATA ANALYSIS (2024–2026). IJITSS. 2026;5(2(50). doi:10.31435/ijitss.2(50).2026.5685